International Journal of Infection

Published by: Kowsar

Sofosbuvir-Containing Regimen for the Treatment of Hepatitis C Virus in a Patient With Sickle-Thalassemia: The First Case Report

Nawfal R Hussein 1 , *
Author Information
1 Department of Internal Medicine, College of Medicine, University of Duhok, Duhok, Iraq
Article information
  • International Journal of Infection: January 01, 2017, 4 (1); e38077
  • Published Online: July 17, 2016
  • Article Type: Case Report
  • Received: March 27, 2016
  • Accepted: April 15, 2016
  • DOI: 10.17795/iji-38077

To Cite: Hussein N R. Sofosbuvir-Containing Regimen for the Treatment of Hepatitis C Virus in a Patient With Sickle-Thalassemia: The First Case Report, Int J Infect. 2017 ; 4(1):e38077. doi: 10.17795/iji-38077.

Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
  • 1. Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015; 61(1): 77-87[DOI][PubMed]
  • 2. Hui CK, Monto A, Belaye T, Lau E, Wright TL. Outcomes of interferon alpha and ribavirin treatment for chronic hepatitis C in patients with normal serum aminotransaminases. Gut. 2003; 52(11): 1644-8[PubMed]
  • 3. Li CK, Chan PK, Ling SC, Ha SY. Interferon and ribavirin as frontline treatment for chronic hepatitis C infection in thalassaemia major. Br J Haematol. 2002; 117(3): 755-8[PubMed]
  • 4. Hussein NR, Tunjel I, Basharat Z, Taha A, Irving W. The treatment of HCV in patients with haemoglobinopathy in Kurdistan Region, Iraq: a single centre experience. Epidemiol Infect. 2016; 144(8): 1634-40[DOI][PubMed]
  • 5. Jazwinski AB, Muir AJ. Direct-acting antiviral medications for chronic hepatitis C virus infection. Gastroenterol Hepatol (N Y). 2011; 7(3): 154-62[PubMed]
  • 6. Mirmomen S, Alavian SM. Treatment of hcv infection in multitransfused thalassemic patients: Does liver iron status affect the outcome of response. Hepat Mon. 2005; 5(1): 111-3
  • 7. Tabatabaei SV, Alavian SM, Keshvari M, Behnava B, Miri SM, Karimi Elizee P, et al. Low dose ribavirin for treatment of hepatitis C virus infected thalassemia major patients; new indications for combination therapy. Hepat Mon. 2012; 12(6): 372-81[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments